Fierce market competition seen in anti-hypertension drugs.

Published: 2001-02-15 15:36:00

Updated: 2001-02-15 15:36:00

To meet the winter seasonal market demands for anti-hypertensive market, the total potentiality of which estimated to 250 billion won, most of leading local pharmaceutical companies are trying to introduce better competitive drugs for hypertensive patients.

Hanmi put Univasc on the market las...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK